Target intelligence / Profile preview

Dermatophagoides pteronyssinus allergen 1 substrates (Der p 1 substrates)

Target
Der p 1 substrates
Molecular classification
Cell adhesion molecule, Tight junction protein, Cell surface receptor, Surfactant protein
01

Overview

Der p 1 substrates on airway epithelial and endothelial cell surfaces are a group of proteins targeted by the cysteine protease allergen Der p 1 from the house dust mite Dermatophagoides pteronyssinus. These substrates include critical junctional proteins such as Occludin, Claudin-1, Zonula occludens-1 (ZO-1), and E-cadherin, which are essential for maintaining the physical integrity of the airway barrier [Wan et al., 1999; Gough et al., 2001]. Proteolytic cleavage of these proteins by Der p 1 increases epithelial permeability, facilitating the entry of allergens and pathogens into the subepithelial space. Additionally, Der p 1 cleaves cell surface receptors like CD23 (low-affinity IgE receptor) and CD25 (IL-2 receptor alpha chain), which modulates immune signaling and promotes a Th2-biased allergic response [Schulz et al., 1998]. The allergen also activates Protease-activated receptor 2 (PAR-2), inducing the secretion of pro-inflammatory cytokines such as IL-6 and IL-8 [Asokananthan et al., 2002]. Therapeutic interventions aim to inhibit the enzymatic activity of Der p 1 using small molecule cysteine protease inhibitors, thereby protecting these substrates from degradation and preventing the initiation of allergic inflammation and asthma exacerbations.

Other names
House dust mite allergen 1 substratesHDM allergen 1 substratesDer p 1 cleavage targetsAirway epithelial junctional proteinsCD23 and CD25 receptors
02

Mechanism of action

Inhibition of the Der p 1 cysteine protease prevents the proteolytic cleavage and degradation of these substrates, thereby preserving airway barrier integrity and preventing pro-inflammatory signaling cascades.

03

Biological functions

Epithelial barrier maintenanceImmune response regulationCell-cell adhesionSignal transduction
04

Disease associations

AsthmaAllergic rhinitisAtopic dermatitisInflammation
05

Safety considerations

Off-target inhibition of endogenous human cysteine proteasesPotential interference with normal tissue remodelingSystemic toxicity of broad-spectrum protease inhibitors
06

Interacting drugs

ONO-5334

2 more in the full profile.

07

Biomarkers

Der p 1-specific IgESoluble CD23 (sCD23)Soluble CD25 (sCD25)Transepithelial electrical resistance (TEER)

Beyond the preview

Go deeper on Dermatophagoides pteronyssinus allergen 1 substrates (Der p 1 substrates).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermatophagoides pteronyssinus allergen 1 substrates (Der p 1 substrates).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call